LBTSF
Price
$13.36
Change
+$4.35 (+48.28%)
Updated
Jun 26 closing price
Capitalization
2.79B
LVRLF
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Aug 15 closing price
Capitalization
6.56M
78 days until earnings call
Interact to see
Advertisement

LBTSF vs LVRLF

Header iconLBTSF vs LVRLF Comparison
Open Charts LBTSF vs LVRLFBanner chart's image
Almirall SA
Price$13.36
Change+$4.35 (+48.28%)
Volume$332
Capitalization2.79B
CordovaCann
Price$0.06
Change+$0.01 (+20.00%)
Volume$6.74K
Capitalization6.56M
LBTSF vs LVRLF Comparison Chart in %
Loading...
LBTSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LBTSF vs. LVRLF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBTSF is a Hold and LVRLF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (LBTSF: $13.36 vs. LVRLF: $0.06)
Brand notoriety: LBTSF and LVRLF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LBTSF: 117% vs. LVRLF: 17%
Market capitalization -- LBTSF: $2.79B vs. LVRLF: $6.56M
LBTSF [@Pharmaceuticals: Generic] is valued at $2.79B. LVRLF’s [@Pharmaceuticals: Generic] market capitalization is $6.56M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LBTSF’s FA Score shows that 1 FA rating(s) are green whileLVRLF’s FA Score has 0 green FA rating(s).

  • LBTSF’s FA Score: 1 green, 4 red.
  • LVRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, LBTSF is a better buy in the long-term than LVRLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LBTSF’s TA Score shows that 1 TA indicator(s) are bullish while LVRLF’s TA Score has 5 bullish TA indicator(s).

  • LBTSF’s TA Score: 1 bullish, 1 bearish.
  • LVRLF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LVRLF is a better buy in the short-term than LBTSF.

Price Growth

LBTSF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LVRLF (@Pharmaceuticals: Generic) price change was +32.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

LVRLF is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LBTSF($2.79B) has a higher market cap than LVRLF($6.56M). LVRLF YTD gains are higher at: 49.250 vs. LBTSF (45.645).
LBTSFLVRLFLBTSF / LVRLF
Capitalization2.79B6.56M42,548%
EBITDA195MN/A-
Gain YTD45.64549.25093%
P/E Ratio115.12N/A-
Revenue1.05BN/A-
Total Cash323MN/A-
Total Debt405MN/A-
FUNDAMENTALS RATINGS
LBTSF vs LVRLF: Fundamental Ratings
LBTSF
LVRLF
OUTLOOK RATING
1..100
4319
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
97
Overvalued
PROFIT vs RISK RATING
1..100
89100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
4045
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
5033

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LBTSF's Valuation (31) in the null industry is significantly better than the same rating for LVRLF (97). This means that LBTSF’s stock grew significantly faster than LVRLF’s over the last 12 months.

LBTSF's Profit vs Risk Rating (89) in the null industry is in the same range as LVRLF (100). This means that LBTSF’s stock grew similarly to LVRLF’s over the last 12 months.

LBTSF's SMR Rating (90) in the null industry is in the same range as LVRLF (100). This means that LBTSF’s stock grew similarly to LVRLF’s over the last 12 months.

LBTSF's Price Growth Rating (40) in the null industry is in the same range as LVRLF (45). This means that LBTSF’s stock grew similarly to LVRLF’s over the last 12 months.

LBTSF's P/E Growth Rating (88) in the null industry is in the same range as LVRLF (100). This means that LBTSF’s stock grew similarly to LVRLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LBTSFLVRLF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
15%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bearish Trend 3 days ago
17%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
14%
Bullish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
13%
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
72%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LBTSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNKD3.730.03
+0.81%
MannKind Corp
CLNN3.620.02
+0.56%
Clene Inc.
ALCO32.81-0.54
-1.62%
Alico
ENB47.04-1.14
-2.37%
Enbridge
VLY9.82-0.24
-2.39%
Valley National Bancorp

LBTSF and

Correlation & Price change

A.I.dvisor tells us that LBTSF and IPSEY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LBTSF and IPSEY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LBTSF
1D Price
Change %
LBTSF100%
N/A
IPSEY - LBTSF
16%
Poorly correlated
N/A
MEDXF - LBTSF
10%
Poorly correlated
+4.22%
LVRLF - LBTSF
3%
Poorly correlated
+19.28%
MKGAF - LBTSF
3%
Poorly correlated
+1.94%
KSPHF - LBTSF
0%
Poorly correlated
N/A
More

LVRLF and

Correlation & Price change

A.I.dvisor tells us that LVRLF and MCUJF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LVRLF and MCUJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVRLF
1D Price
Change %
LVRLF100%
+19.28%
MCUJF - LVRLF
16%
Poorly correlated
N/A
MEDIF - LVRLF
7%
Poorly correlated
-7.67%
KHTRF - LVRLF
6%
Poorly correlated
N/A
KSPHF - LVRLF
5%
Poorly correlated
N/A
LBTSF - LVRLF
3%
Poorly correlated
N/A
More